$102.08 -1.52 (-1.47%)
2/10/2012 4:00 PM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Featured Broker Partners


Advertisement